On Tuesday, April 10, 2012, the DOT issued a reminder about important 40 CFR Part 40 regulatory requirements to Medical Review Officers (MROs), Consortia/Third Party Administrators (C/TPAs), collectors and employers. The following are the key points.
Molly, derived from the word molecule is commonly used as a recreational drug. The chemical make-up is 4-Methylmethcathinone (4-MMC) and 4-Methyl-N-Ethylcathinone (4-MEC) or MDMA. 4-MMC and 4-MEC are controlled substance analogues of methcathinone, a Schedule I controlled substance. Molly, is MDMA that is sold in powered or crystallized form. When MDMA is sold as a tablet it is commonly sold as “Ecstasy.”
Companies that are required to conduct random drug and alcohol testing under the DOT are subject to many rules to ensure compliance throughout the process. Listed below are a few tips to help complete the random testing process successfully.
Reed Morrison, Ph.D. will deliver a presentation on Thursday, April 19th to the attendees of this year’s annual DATIA Conference. The conference which will be held on April 18th - 20th in San Antonio, TX is a gathering of drug and alcohol testing industry professionals and vendors. Dr. Morrison’s workshop is entitled “The New Paradigm and the DOT SAP Return to Duty Process: An Interview with Sandra Sapp.”
Scientists have been testing a new treatment for alcoholism.
The Drug Enforcement Administration (DEA) issued a final rule extending the temporary placement of five synthetic cannabinoids into Schedule I of the Controlled Substances Act. Along with the banned cannabinoids are the salts, isomers and salts of isomers related to the substances. The extension of this temporary placement comes at the expiration of a previous temporary scheduling which expired on February 29, 2012. The ruling will extend the scheduling to August 29, 2012 or until rulemaking proceedings are completed, whichever is shorter.
ASAP VP of Business Development, Laura Dashner will co-present during a BIG Initiative SBIRT Education webinar. The one-hour webinar entitled EAP, SBIRT and DOT-Covered Employees will outline methods for recognizing special considerations for following SBIRT protocols with DOT-covered employees, action steps to take in the event of a DOT rule violation, and strategies for dealing with voluntary disclosure of substance use problems with DOT-covered employees. The online event is scheduled for Thursday, March 29th from 3PM to 4PM.
American Substance Abuse Professionals® will conduct a training at an Occupational Health Conference on March 3rd in Dallas, Texas. The training will cover new DOT regulations and trends with a special focus on schedule I drugs, refusal to test, and actual knowledge. Also covered will be the updated information about increasingly popular designer drugs like K2 Spice and Bath Salts. The audience which will be comprised of occupational health nurses and professionals will learn about impact of designer drugs on DOT safety sensitive duties and the workplace in general.&nb
According to SAMHSA publication, more than 6 million children live with at least one parent who abuses or is dependent on alcohol or an illicit drug. Children of alcoholics (COAs) are four times more likely than non-COAs to develop alcoholism or drug problems. Additionally, they are at a higher risk than others for problems with cognitive and verbal skills, anxiety disorders, depression and parental abuse and neglect.
The U.S. Department of Transportation, Office of Drug and Alcohol Policy and Compliance recently released a statement clarifying an issue regarding Medical Review Officers (MROs) contacting an employee’s treating physicians. In short, HIPAA rules do not apply to MROs carrying out their verification process duties under 49 CFR Part 40.
In part, the rule states:
Effective, February 29, 2012, the Federal Motor Carrier Safety Administration (FMCSA) published a final rule for drivers regarding physical qualifications, drug/alcohol testing and inaccurate use of the term actual knowledge.
Schedule I Drugs Prohibited
According to a study conducted by SAMHSA1, adults on average wait 15 years between the time they first use drugs and the time they are admitted for treatment. In 2010, among the nearly 670,000 adults admitted for substance abuse treatment for the first time “an average of 15.6 years had elapsed since the first time they started using the substance they were primarily being treated for.” On average men (16.5 year average) are waiting longer to seek treatment than women (13.8 year average). Alcohol had the longest lag between first time usage and treat
Methamphetamine also known as Meth, Crystal, Crank and Speed is a highly addictive central nervous system stimulant. Chronic use can lead to paranoia, hallucinations and violent behavior. Long-term use and/or high dosages can lead to toxic psychosis, stroke, heart attack and death.
In an effort to raise awareness about the growing epidemic of people addicted to Meth and the dangers associated with it, The Meth Project Foundation was established in 2005 by Thomas M. Siebel chairman of First Virtual Group.
During the 2011 Holiday Season ASAP partnered with some of our local clients and associates to collect care packages for America's veterans in need at the MCVET outreach facility in Baltimore, Maryland.
Soap, toothpaste, hats, gloves and several other personal care products were collected. The efforts yielded over 100 care packages for veterans in transition some of whom are dealing with substance abuse issues.
ASAP would like to thank all the volunteers and contributors at the following sites:
The Compliance, Safety, Accountability (CSA) program which establishes a nationwide system for making the roads safer for motor carriers and the public recently released a new Behavior Analysis and Safety Improvement Category (BASIC) factsheet series. “Generally CSA affects carriers subject to the Federal Motor Carrier Safety Regulations (FMCSRs), carriers transporting passengers or cargo in interstate commerce, and carriers of hazardous materials in intrastate commerce, but may also include carriers whose State requires that they obtain a U.S.
In late 2011, SAMHSA announced a working definition of recovery from substance use disorders and mental disorders. The definition was developed as a result of the efforts of SAMHSA’s Recovery Support Strategic Initiative. SAMHSA worked with behavioral health leaders, mental health consumers and individuals in addiction recovery to develop a draft definition and principles of recovery. The aim was to develop terminology that commonly reflected the recovery experience for individuals with substance use disorders and/or mental health disorders.
Drug Testing Advisory Board’s (DTAB), July 2011 recommendations have been approved by the Dept of Health and Human Services SAMHSA Administrator Pamela S. Hyde. J.D. The recommendations are as follows:
On July 8, 2011 a petition to reclassify marijuana from a Schedule I to a Schedule II or III drug was rejected for the third time in US history.
ASAP offers quality DOT SAP evaluations and case management services. Our trained and knowledgeable staff work to ensure that each DOT SAP evaluation and case is handled efficiently and according to DOT regulations.